S状結腸鏡の世界市場：洞察、競合情勢、市場予測：2032年

S状結腸鏡の市場規模は、2025年から2032年までの予測期間中に5.57%のCAGRで拡大すると予測されています。S状結腸鏡市場は、大腸がん、炎症性腸疾患（IBD）、憩室炎、ポリープなどの慢性疾患の増加、高齢者人口の増加、胃腸疾患の早期診断に対する意識の高まり、低侵襲処置へのシフトの増加などにより大きく成長しており、2025年から2032年までの予測期間中にS状結腸鏡の需要をエスカレートさせると予測されています。

S状結腸鏡市場力学：

Global Cancer Observatory（2024）によると、大腸がんはアジアで50.2%、欧州で27.9%、アフリカで3.7%を占めています。また、同出典によれば、2022年には世界で約139万人の大腸がん患者が発生し、2045年には329万人に達すると予測されています。このような世界の負担の増加は、早期発見と診断の必要性が高まり続ける中、S状結腸鏡の需要を大きく押し上げています。

S状結腸鏡は、大腸がんの早期発見において重要な役割を果たしています。S状結腸鏡によって、医師はがんやポリープの好発部位である直腸やS状結腸を直接可視化することができます。その結果、S状結腸鏡は予防ヘルスケアや日常診断プロトコルの重要な構成要素になりつつあります。

さらに、World Gastroenterology Organization（2024）は、女性の49％、男性の36.6％が少なくとも1つの機能性胃腸障害（FGID）の基準を満たしていると報告しています。最も多い疾患は、機能性便秘（11.7％）、機能性ディスペプシア（7.2％）、直腸痛（5.9％）、機能性下痢（4.7％）、過敏性腸症候群（IBS）（4.1％）でした。これらの疾患の多くは、正確な診断と治療計画のために直腸とS状結腸の直接検査を必要とするため、S状結腸鏡検査の採用は病院、診療所、消化器センターで急増しています。

さらに、世界のがん罹患率の増加が予想される中、ヘルスケアシステムは高度な診断ツールや技術への投資を増やしています。早期発見と予防医療がより重視されています。例えば、2024年1月、Olympus CorporationはTaewoong Medical Co, Ltd.を3億7,000万米ドルで買収しました。この戦略的買収は、Olympusの消化器内治療ポートフォリオを拡大し、消化器疾患の診断・治療機器の両面における能力を強化することを目的としています。

さらに、世界保健機関（WHO）によると（2024年）、2050年までに世界の高齢者人口の約80％が低・中所得国に居住することになります。高齢者は早期診断が必要な消化器疾患にかかりやすいため、S状結腸鏡のような利用しやすい診断ソリューションに対する需要は、特に新興市場で大幅に増加すると予想されます。

したがって、大腸がん罹患率の上昇、FGIDsの罹患率の増加、高齢者人口の増加、ヘルスケアの進歩の組み合わせが、2025年から2032年までの予測期間中にS状結腸鏡市場の力強い成長を促進すると予想されます。

しかし、代替診断法の利用可能性、S状結腸鏡検査に伴う合併症や感染症の潜在的リスク、患者の不快感などによる一定の制限に直面する可能性があり、普及の妨げになる可能性があります。

S状結腸鏡市場セグメント分析：

製品タイプ（硬性、軟性）、使用性（使い捨て、再利用）、エンドユーザー（病院・クリニック、外来手術センター、その他）、地域（北米、欧州、アジア太平洋、その他の地域）別のS状結腸鏡市場分析

S状結腸鏡の製品タイプ別では、2024年には軟性カテゴリーが大きな収益シェアを占めると予想されています。これは、硬性モデルと比較して多くの利点があるためです。軟性S状結腸鏡の採用拡大がS状結腸鏡市場全体を大きく押し上げており、その主な理由は臨床的有用性の向上、患者の快適性、進化する技術にあります。硬性S状結腸鏡とは異なり、軟性S状結腸鏡はS状結腸をより深く観察でき、操作性も良いため、医師はより高い精度で異常を発見できます。

さらに、これらの器具は苦痛が少なく、鎮静剤を必要としないことが多く、外来での処置が可能であるため、より利用しやすく、費用対効果が高いです。例えば、内視鏡の世界的リーダーであるOlympus Corporationは、高精細画像と粘膜可視化を強化するNBI（Narrow Band Imaging）技術で知られるEVIS EXERA IIIプラットフォームの一部として、先進的な軟性S状結腸鏡を提供しています。これにより、大腸ポリープや早期がん病変の検出が向上します。Pentax Medicalは、人間工学に基づいたデザインとHD+可視化を特徴とするEC-3490LKのような軟性ビデオS状結腸鏡を製造しており、消化器病棟やクリニックで広く使用されています。これらの技術革新により、特に医療システムが大腸がんの予防医療を重視する中、軟性S状結腸鏡検査は定期的な大腸スクリーニング検査においてより魅力的なものとなっています。

さらに、Ambu A/Sのような企業は、Ambu（R）aScope Gastroのような使い捨ての軟性S状結腸鏡を発売し、利便性と無菌性を提供しながら、感染管理の懸念に対処しています。英国のNHS Bowel Scope Screeningのような国のがん検診プログラムに軟性S状結腸鏡が統合されたことで、臨床への導入がさらに加速しています。全体として、軟性S状結腸鏡への依存の高まりは、光学的透明性、デジタル画像処理、およびシングルユース形式の改善と相まって、S状結腸鏡市場の世界の成長を促進する上で極めて重要な役割を果たしています。

北米はS状結腸鏡市場全体を支配すると予想されている：

すべての地域の中で、北米は2024年にS状結腸鏡市場を独占すると予想されています。これは、技術の進歩、規制当局の承認、主要企業の大きな市場プレゼンス、ヘルスケアインフラへの継続的な投資、2025年から2032年までの予測期間中にS状結腸鏡市場を牽引すると期待される革新的な製品開発によって強化された大腸がん患者の増加などのいくつかの要因に起因することができます。

国際がん研究機関のデータ（2024年）によると、北米における新規大腸がん患者数は約18万4,000人で、この数字は2050年までに25万人に増加すると予測されています。大腸がんの罹患率が増加の一途をたどる中、早期発見と効果的なスクリーニング方法の必要性がより重要になってきています。直腸とS状結腸を検査する重要な診断法であるS状結腸鏡検査は、結腸直腸の異常の発見とモニタリングに重要な役割を果たしています。大腸がんの負担が増加する中、S状結腸鏡の需要は増加しており、ヘルスケアプロバイダーはタイムリーな診断と介入のためにこのツールにますます依存しています。

さらに、米国消化器病学会（2024）は、約6,000～7,000万人の米国人が胃腸（GI）疾患に罹患していると報告しています。炎症性腸疾患（IBD）、潰瘍性大腸炎、直腸炎、憩室症、大腸ポリープなどの疾患の有病率の増加が、S状結腸鏡の需要をさらに押し上げています。これらの疾患は一般的に下部消化管、特に直腸とS状結腸領域に影響を及ぼし、S状結腸鏡を使って最もよく可視化されます。例えば、潰瘍性大腸炎の患者は、粘膜の炎症を監視し、治療効果を評価するために、しばしば定期的なS状結腸鏡検査を必要とします。

さらに、Johnson &Johnson Services, Inc.、Olympus Corporation、Baxterなどの主要企業が強固な流通網を背景に存在するため、S状結腸鏡はこの地域で広く利用され、入手しやすくなっています。さらに、有利な償還政策が採用をさらに後押しし、大きな市場成長機会を生み出しています。

結論として、大腸がんと消化器疾患の有病率の上昇は、技術的なアクセシビリティ、強力な市場参入企業、および支持的なヘルスケア政策と相まって、北米のS状結腸鏡市場の大幅な成長を促進すると予想されます。

S状結腸鏡市場の主要企業

S状結腸鏡市場で事業を展開している主要な市場参入企業には、Olympus Corporation、Baxter、Adler Instrument Company、Bioseal Inc.、Rocket Medical plc.、ConMed Corporation、Johnson &Johnson Services, Inc.、Medtronic、Ambu A/S、SCHOLLY FIBEROPTIC GMBH、SonoScape Medical Corp.、Interscope, Inc.、Ovesco Endoscopy AGなどがあります。

S状結腸鏡市場における最近の開発活動：

• 2024年2月、FUJIFILM Indiaは画期的なALOKA ARIETTA 850 Diagnostic Ultrasound Systemをインドで発売しました。このハイテク超音波システムは、同地域における消化器疾患の診断精度と画像の鮮明さを高めることを目的としています。
• 2023年5月、Olympus はEVIS X1内視鏡システムと2つの互換性のある胃腸内視鏡のFDA認可を発表しました。GIF-1100 gastrointestinal videoscopeは食道、胃、十二指腸を含む上部消化管内での使用に適応され、CF-HQ1100DL/I colonovideoscopeは肛門、直腸、S状結腸、結腸、回盲弁を含む下部消化管内での使用に適応されました。

S状結腸鏡市場調査レポートからの主なポイント

• S状結腸鏡の現在の市場規模分析（2024年）、8年間（2025年～2032年）の市場予測
• 過去3年間に起こった主な製品/サービス開発、合併、買収、パートナーシップ、合弁事業
• S状結腸鏡市場を独占する主要企業
• S状結腸鏡市場において競合他社が利用できる様々な機会
• 2024年に上位を占めるセグメントは何か？2032年におけるこれらのセグメントの業績
• 現在のS状結腸内視鏡市場シナリオで上位を占める地域と国
• 今後、S状結腸鏡市場の成長機会に企業が集中すべき地域や国

S状結腸鏡市場のよくある質問

1.S状結腸鏡

• S状結腸鏡は、大腸の下部である直腸やS状結腸を検査するための医療機器です。異常（ポリープ、炎症、がん）の特定、炎症性腸疾患のモニタリング、生検の実施など、診断および治療処置に一般的に使用されます。

2.S状結腸鏡の市場

• S状結腸鏡市場は、2025年から2032年までの予測期間中にCAGR 5.57%で成長すると予測されています。

3.S状結腸鏡市場の促進要因は

• S状結腸鏡市場は、大腸がん、炎症性腸疾患（IBD）、憩室炎、ポリープなどの慢性疾患の増加、高齢者人口の増加、胃腸疾患の早期診断に対する意識の高まり、低侵襲処置へのシフトの増加などにより大きく成長しており、2025年から2032年までの予測期間中にS状結腸鏡の需要をエスカレートさせると予測されています。

4.S状結腸鏡市場に参入している主要企業は？

• S状結腸鏡市場で事業を展開している主要な市場参入企業には、Olympus Corporation、Baxter、Adler Instrument Company、Bioseal Inc.、Rocket Medical plc.、ConMed Corporation、Johnson &Johnson Services, Inc.、Medtronic、Ambu A/S、SCHOLLY FIBEROPTIC GMBH、SonoScape Medical Corp.、Interscope, Inc.、Ovesco Endoscopy AGなどがあります。

5.S状結腸鏡市場で最もシェアが高い地域

• すべての地域の中で、北米が2024年にS状結腸鏡市場を独占すると予想されています。これは、技術の進歩、規制当局の承認、主要企業の大きな市場プレゼンス、ヘルスケアインフラへの継続的な投資、2025年から2032年までの予測期間中にS状結腸鏡の市場を牽引すると予想される革新的な製品開発別強化された大腸がん患者の増加など、いくつかの要因に起因することができます。

目次

第1章 S状結腸鏡市場レポートのイントロダクション

第2章 S状結腸鏡市場のエグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 S状結腸鏡市場の主な要因分析

• S状結腸鏡市場促進要因
  • 大腸がんや胃腸疾患の増加
  • 高齢化人口の増加
  • 胃腸疾患の早期診断に関する意識の高まり
• S状結腸鏡市場抑制要因と課題
  • 代替オプションの利用可能性
  • これらのデバイスに関連する合併症や感染症のリスク
• S状結腸鏡の市場機会
  • S状結腸鏡と遠隔医療プラットフォームおよびAI支援診断の統合

第6章 シグモイドスコープ市場ポーターのファイブフォース分析

第7章 S状結腸鏡市場の評価

• 製品タイプ別
  • 硬性
  • 軟性
• ユーザビリティ別
  • ディスポーザブル
  • 再利用型
• エンドユーザー別
  • 病院と診療所
  • 外来手術センター
  • その他
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 S状結腸鏡市場の企業と製品プロファイル

• Olympus Corporation
• Baxter
• Adler Instrument Company
• Bioseal Inc.
• Rocket Medical plc.
• ConMed Corporation
• Johnson & Johnson Services, Inc.
• Medtronic
• Ambu A/S
• SCHOLLY FIBEROPTIC GMBH
• SonoScape Medical Corp.
• Interscope, Inc.
• Ovesco Endoscopy AG

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Sigmoidoscopes Market in Global (2022-2032)
• Table 3: Sigmoidoscopes Market in Global by Product Type (2022-2032)
• Table 4: Sigmoidoscopes Market in Global by Usability (2022-2032)
• Table 5: Sigmoidoscopes Market in Global by End-User (2022-2032)
• Table 6: Sigmoidoscopes Market in Global by Geography (2022-2032)
• Table 7: Sigmoidoscopes Market in North America (2022-2032)
• Table 8: Sigmoidoscopes Market in the United States (2022-2032)
• Table 9: Sigmoidoscopes Market in Canada (2022-2032)
• Table 10: Sigmoidoscopes Market in Mexico (2022-2032)
• Table 11: Sigmoidoscopes Market in Europe (2022-2032)
• Table 12: Sigmoidoscopes Market in France (2022-2032)
• Table 13: Sigmoidoscopes Market in Germany (2022-2032)
• Table 14: Sigmoidoscopes Market in United Kingdom (2022-2032)
• Table 15: Sigmoidoscopes Market in Italy (2022-2032)
• Table 16: Sigmoidoscopes Market in Spain (2022-2032)
• Table 17: Sigmoidoscopes Market in Rest of Europe (2022-2032)
• Table 18: Sigmoidoscopes Market in Asia-Pacific (2022-2032)
• Table 19: Sigmoidoscopes Market in China (2022-2032)
• Table 20: Sigmoidoscopes Market in Japan (2022-2032)
• Table 21: Sigmoidoscopes Market in India (2022-2032)
• Table 22: Sigmoidoscopes Market in Australia (2022-2032)
• Table 23: Sigmoidoscopes Market in South Korea (2022-2032)
• Table 24: Sigmoidoscopes Market in Rest of Asia-Pacific (2022-2032)
• Table 25: Sigmoidoscopes Market in Rest of the World (2022-2032)
• Table 26: Sigmoidoscopes Market in the Middle East (2022-2032)
• Table 27: Sigmoidoscopes Market in Africa (2022-2032)
• Table 28: Sigmoidoscopes Market in South America (2022-2032)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Sigmoidoscopes Market in Global (2022-2032)
• Figure 3: Sigmoidoscopes Market in Global by Product Type (2022-2032)
• Figure 4: Sigmoidoscopes Market in Global by Usability (2022-2032)
• Figure 5: Sigmoidoscopes Market in Global by End-User (2022-2032)
• Figure 6: Sigmoidoscopes Market in Global by Geography (2022-2032)
• Figure 7: Sigmoidoscopes Market in North America (2022-2032)
• Figure 8: Sigmoidoscopes Market in the United States (2022-2032)
• Figure 9: Sigmoidoscopes Market in Canada (2022-2032)
• Figure 10: Sigmoidoscopes Market in Mexico (2022-2032)
• Figure 11: Sigmoidoscopes Market in Europe (2022-2032)
• Figure 12: Sigmoidoscopes Market in France (2022-2032)
• Figure 13: Sigmoidoscopes Market in Germany (2022-2032)
• Figure 14: Sigmoidoscopes Market in United Kingdom (2022-2032)
• Figure 15: Sigmoidoscopes Market in Italy (2022-2032)
• Figure 16: Sigmoidoscopes Market in Spain (2022-2032)
• Figure 17: Sigmoidoscopes Market in Rest of Europe (2022-2032)
• Figure 18: Sigmoidoscopes Market in Asia-Pacific (2022-2032)
• Figure 19: Sigmoidoscopes Market in China (2022-2032)
• Figure 20: Sigmoidoscopes Market in Japan (2022-2032)
• Figure 21: Sigmoidoscopes Market in India (2022-2032)
• Figure 22: Sigmoidoscopes Market in Australia (2022-2032)
• Figure 23: Sigmoidoscopes Market in South Korea (2022-2032)
• Figure 24: Sigmoidoscopes Market in Rest of Asia-Pacific (2022-2032)
• Figure 25: Sigmoidoscopes Market in Rest of the World (2022-2032)
• Figure 26: Sigmoidoscopes Market in the Middle East (2022-2032)
• Figure 27: Sigmoidoscopes Market in Africa (2022-2032)
• Figure 28: Sigmoidoscopes Market in South America (2022-2032)
• Figure 29: Market Drivers
• Figure 30: Market Barriers
• Figure 31: Marker Opportunities
• Figure 32: PORTER'S Five Force Analysis

Sigmoidoscopes Market by Product Type (Rigid and Flexible), Usability (Disposable and Reusable), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2032 owing to the increasing instances of chronic conditions and rising awareness about early diagnosis of gastro-intestinal disorders globally.

The sigmoidoscopes market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032. The sigmoidoscopes market is growing significantly due to the increasing instances of chronic conditions such colorectal cancer, inflammatory bowel diseases (IBD), diverticulitis, and polyps, growing geriatric population, rising awareness about early diagnosis of gastro-intestinal disorders, increasing shift towards minimally invasive procedures, and others that are expected to escalate the demand for sigmoidoscopes during the forecast period from 2025 to 2032.

Sigmoidoscopes Market Dynamics:

According to the Global Cancer Observatory (2024), colorectal cancer accounted for 50.2% of cancer cases in Asia, 27.9% in Europe, and 3.7% in Africa. The same source also reported that in 2022, there were approximately 1.39 million cases of colorectal cancer worldwide, a number projected to reach 3.29 million by 2045. This rising global burden is significantly driving the demand for sigmoidoscopes, as the need for early detection and diagnosis continues to grow.

Sigmoidoscopy plays a critical role in the early identification of colorectal cancer. It allows physicians to directly visualize the rectum and sigmoid colon, which are common sites for cancer and polyps. As a result, sigmoidoscopes are increasingly becoming a key component of preventive healthcare and routine diagnostic protocols.

In addition, the World Gastroenterology Organization (2024) reported that 49% of females and 36.6% of males met the criteria for at least one functional gastrointestinal disorder (FGID). The most prevalent disorders included functional constipation (11.7%), functional dyspepsia (7.2%), proctalgia fugax (5.9%), functional diarrhea (4.7%), and irritable bowel syndrome (IBS) (4.1%). Since many of these conditions require direct examination of the rectum and sigmoid colon for accurate diagnosis and treatment planning, the adoption of sigmoidoscopy procedures has surged across hospitals, clinics, and gastroenterology centers.

Furthermore, with the expected rise in global cancer incidence, healthcare systems are increasingly investing in advanced diagnostic tools and technologies. A greater emphasis is being placed on early detection and preventive care. For instance, in January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd. for USD 370 million. This strategic acquisition is aimed at expanding Olympus's gastrointestinal endotherapy portfolio and strengthening its capabilities in both diagnostic and therapeutic devices for GI disorders.

Moreover, according to the World Health Organization (2024), by 2050, around 80% of the global elderly population will reside in low- and middle-income countries. As older adults are more prone to gastrointestinal issues that require early diagnosis, the demand for accessible diagnostic solutions such as sigmoidoscopes is expected to increase significantly, especially in emerging markets.

Therefore, the combination of rising colorectal cancer prevalence, increasing incidence of FGIDs, growing geriatric population, and healthcare advancements is anticipated to drive robust growth in the sigmoidoscope market during the forecast period from 2025 to 2032.

However, the market may face certain limitations due to the availability of alternative diagnostic methods, potential risks of complications and infections associated with sigmoidoscopy, and patient discomfort, which could hinder its widespread adoption.

Sigmoidoscopes Market Segment Analysis:

Sigmoidoscopes Market by Product Type (Rigid and Flexible), Usability (Disposable and Reusable), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of sigmoidoscopes, the flexible category is expected to have a significant revenue share in the year 2024. This is due to the numerous advantages over rigid models. The growing adoption of flexible sigmoidoscopes is significantly boosting the overall market for sigmoidoscopes, largely due to their enhanced clinical utility, patient comfort, and evolving technology. Unlike rigid sigmoidoscopes, flexible variants allow for deeper navigation of the sigmoid colon and better maneuverability, enabling physicians to detect abnormalities with greater accuracy.

Additionally, these devices are less painful, often do not require sedation, and allow for procedures to be performed in outpatient settings, making them more accessible and cost-effective. For instance, Olympus Corporation, a global leader in endoscopy, offers advanced flexible sigmoidoscopes that are part of its EVIS EXERA III platform, known for high-definition imaging and Narrow Band Imaging (NBI) technology that enhances mucosal visualization. This allows for improved detection of colorectal polyps and early-stage cancer lesions. Another notable example is Pentax Medical, which manufactures flexible video sigmoidoscopes such as the EC-3490LK, featuring ergonomic design and HD+ visualization, widely used in GI units and clinics. These innovations have made flexible sigmoidoscopy more appealing for routine colorectal screenings, especially as health systems emphasize preventive care for colorectal cancer.

Additionally, companies like Ambu A/S have introduced single-use flexible sigmoidoscopes, such as the Ambu(R) aScope Gastro, addressing infection control concerns while offering convenience and sterility. The integration of flexible sigmoidoscopy into national cancer screening programs such as the NHS Bowel Scope Screening in the UK has further accelerated its clinical adoption. Overall, the increasing reliance on flexible sigmoidoscopes, combined with improvements in optical clarity, digital imaging, and single-use formats, is playing a pivotal role in driving the growth of the sigmoidoscope market globally.

North America is expected to dominate the overall sigmoidoscopes market:

Among all the regions, North America is expected to dominate the sigmoidoscopes market in the year 2024. This can be attributed to several factors, such as rising colorectal cancer cases, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for sigmoidoscopes during the forecast period from 2025 to 2032.

According to data from the International Agency for Research on Cancer (2024), the number of new colorectal cancer cases in North America was approximately 184,000, and this figure is projected to rise to 250,000 by 2050. As the incidence of colorectal cancer continues to increase, the need for early detection and effective screening methods becomes more critical. Sigmoidoscopy, a key diagnostic procedure for examining the rectum and sigmoid colon, plays a vital role in identifying and monitoring colorectal abnormalities. With the rising burden of colorectal cancer, the demand for sigmoidoscopes is growing, as healthcare providers increasingly rely on this tool for timely diagnosis and intervention.

Additionally, the American Gastroenterological Association (2024) reported that approximately 60-70 million Americans are affected by gastrointestinal (GI) diseases. The increasing prevalence of conditions such as inflammatory bowel disease (IBD), ulcerative colitis, proctitis, diverticulosis, and colorectal polyps is further driving the demand for sigmoidoscopes. These disorders commonly affect the lower gastrointestinal tract, specifically the rectum and sigmoid colon areas, best visualized using a sigmoidoscope. For instance, patients with ulcerative colitis often require regular sigmoidoscopic evaluations to monitor mucosal inflammation and assess treatment response.

Moreover, the presence of key industry players such as Johnson & Johnson Services, Inc., Olympus Corporation, and Baxter, backed by robust distribution networks, ensures wide accessibility and availability of sigmoidoscopes across the region. In addition, favorable reimbursement policies further support adoption, creating significant market growth opportunities.

In conclusion, the rising prevalence of colorectal cancer and GI diseases, combined with technological accessibility, strong market players, and supportive healthcare policies, are expected to foster substantial growth for the sigmoidoscope market in North America.

Sigmoidoscopes Market Key Players:

Some of the key market players operating in the sigmoidoscopes market include Olympus Corporation, Baxter, Adler Instrument Company, Bioseal Inc., Rocket Medical plc., ConMed Corporation, Johnson & Johnson Services, Inc., Medtronic, Ambu A/S, SCHOLLY FIBEROPTIC GMBH, SonoScape Medical Corp., Interscope, Inc., Ovesco Endoscopy AG, and others.

Recent Developmental Activities in the Sigmoidoscopes Market:

• In February 2024, FUJIFILM India launched the groundbreaking ALOKA ARIETTA 850 Diagnostic Ultrasound System in India, representing a significant advancement in endoscopic technologies. The high-tech ultrasound system aimed to enhance diagnostic precision and image clarity for gastrointestinal diseases in the region.
• In May 2023, Olympus announced the FDA clearance of the EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes. The GIF-1100 gastrointestinal videoscope was indicated for use within the upper digestive tract, including the esophagus, stomach, and duodenum, while the CF-HQ1100DL/I colonovideoscope was indicated for use within the lower digestive tract, including the anus, rectum, sigmoid colon, colon, and ileocecal valve.

Key takeaways from the sigmoidoscopes market report study

• Market size analysis for current sigmoidoscopes market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the sigmoidoscopes market
• Various opportunities available for the other competitors in the sigmoidoscopes market space
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current sigmoidoscopes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for sigmoidoscopes market growth in the coming future?

Target audience who can benefit from this sigmoidoscope market report study

• Sigmoidoscopes product providers
• Research organizations and consulting companies
• Sigmoidoscopes-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in sigmoidoscopes
• Various end-users who want to know more about the sigmoidoscopes market and the latest developments in the sigmoidoscopes market

Frequently Asked Questions for the Sigmoidoscopes Market:

1. What are sigmoidoscopes?

• The sigmoidoscope is a medical device used for examining the rectum and sigmoid colon, which is the lower part of the large intestine. It is commonly used in diagnostic and therapeutic procedures, such as identifying abnormalities (polyps, inflammation, or cancer), monitoring inflammatory bowel disease, and performing biopsies.

2. What is the market for sigmoidoscopes?

• The sigmoidoscopes market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032.

3. What are the drivers for the sigmoidoscopes market?

• The sigmoidoscopes market is growing significantly due to the increasing instances of chronic conditions such colorectal cancer, inflammatory bowel diseases (IBD), diverticulitis, and polyps, growing geriatric population, rising awareness about early diagnosis of gastro-intestinal disorders, increasing shift towards minimally invasive procedures, and others that are expected to escalate the demand for sigmoidoscopes during the forecast period from 2025 to 2032.

4. Who are the key players operating in the sigmoidoscopes market?

• Some of the key market players operating in the sigmoidoscopes market include Olympus Corporation, Baxter, Adler Instrument Company, Bioseal Inc., Rocket Medical plc., ConMed Corporation, Johnson & Johnson Services, Inc., Medtronic, Ambu A/S, SCHOLLY FIBEROPTIC GMBH, SonoScape Medical Corp., Interscope, Inc., Ovesco Endoscopy AG, and others.

5. Which region has the highest share in the sigmoidoscopes market?

• Among all the regions, North America is expected to dominate the sigmoidoscopes market in the year 2024. This can be attributed to several factors, such as rising colorectal cancer cases, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for sigmoidoscopes during the forecast period from 2025 to 2032.

Table of Contents

1. Sigmoidoscopes Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Sigmoidoscopes Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Sigmoidoscopes Market Key Factors Analysis

• 5.1. Sigmoidoscopes Market Drivers
  • 5.1.1. Increasing instances of colorectal cancer and gastrointestinal disorders
  • 5.1.2. Increasing geriatric population
  • 5.1.3. Rising awareness about the early diagnosis of gastrointestinal disorders
• 5.2. Sigmoidoscopes Market Restraints and Challenges
  • 5.2.1. Availability of alternative options
  • 5.2.2. Risk of complications and infections associated with these devices
• 5.3. Sigmoidoscopes Market Opportunities
  • 5.3.1. Integration of sigmoidoscopes with telemedicine platforms and AI-assisted diagnostics

6. Sigmoidoscopes Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Sigmoidoscopes Market Assessment

• 7.1. By Product Type
  • 7.1.1. Rigid
  • 7.1.2. Flexible
• 7.2. By Usability
  • 7.2.1. Disposable
  • 7.2.2. Reusable
• 7.3. By End-User
  • 7.3.1. Hospitals & Clinics
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.1.2. Canada Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.1.3. Mexico Sigmoidoscopes Market Size in USD million (2022-2032)
  • 7.4.2. Europe
    • 7.4.2.1. France Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2.2. Germany Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2.3. United Kingdom Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2.4. Italy Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2.5. Spain Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2.6. Rest of Europe Sigmoidoscopes Market Size in USD million (2022-2032)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3.2. Japan Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3.3. India Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3.4. Australia Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3.5. South Korea Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3.6. Rest of Asia-Pacific Sigmoidoscopes Market Size in USD million (2022-2032)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.4.2. Africa Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.4.3. South America Sigmoidoscopes Market Size in USD million (2022-2032)

8. Sigmoidoscopes Market Company and Product Profiles

• 8.1. Olympus Corporation
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Baxter
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. Adler Instrument Company
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Bioseal Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Rocket Medical plc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. ConMed Corporation
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Johnson & Johnson Services, Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Medtronic
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Ambu A/S
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. SCHOLLY FIBEROPTIC GMBH
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. SonoScape Medical Corp.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Interscope, Inc.
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Ovesco Endoscopy AG
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us